Asset Type: Webinars, Discovery, Preclinical Imaging, Radiopharm, Radiopharmaceutical Services, CNS, Discovery, Radiopharmaceutical 
Therapy & Theranostics

Accelerate Translational Research with Quantitative Image Analysis

Accelerate Translational Research with Quantitative Image Analysis

Quantitative Image Analysis for Imaging Biomarkers, Dosimetry and Translational Drug Development

Explore quantitative image analysis, segmentation, imaging biomarkers and dosimetry to generate reproducible data for translational drug development.

Preclinical imaging generates enormous volumes of biological data, but images alone do not answer scientific questions. Meaningful insights depend on rigorous image analysis workflows that transform raw imaging signals into accurate, reproducible quantitative endpoints capable of supporting critical research and regulatory decisions.

This webinar explores the scientific principles behind quantitative image analysis, from segmentation and image quantification to biodistribution, dosimetry and advanced modeling. Attendees will gain practical insight into how standardized analytical workflows improve confidence in imaging biomarkers, reduce variability and strengthen translational decision-making across drug development programs.

Special emphasis will be placed on dosimetry, where quantitative image analysis directly informs human dose estimation through biodistribution modeling, time-activity curve generation and OLINDA-based calculations. Using examples from oncology and radioligand therapy research, attendees will learn why analytical rigor is essential for producing reliable, defensible results.

Download this webinar to discover how robust image analysis transforms preclinical imaging data into actionable evidence that accelerates translational research and supports confident development decisions.

Watch On-Demand

This field is for validation purposes and should be left unchanged.
Subscribe

Meet Our Speaker

Keryn Gresco, MS, Director, Image Analysis and Software Platforms, Perceptive Discovery

Keryn Gresco is a Scientist and Team Leader with more than a decade of experience developing quantitative image analysis workflows for preclinical and translational research. She specializes in image analysis across oncology, radioligand therapy, neurology and systemic diseases, with expertise spanning segmentation, quantitative imaging, dosimetry and software platform development.

As Director of Image Analysis and Software Platforms at Perceptive Discovery, Keryn leads a multidisciplinary team of Scientists, Engineers and Mathematicians responsible for designing and executing image analysis workflows that support studies from early discovery through IND-enabling research. Her team develops standardized analytical methods that transform complex imaging datasets into robust, reproducible endpoints used to inform critical drug development decisions.